Sort
21,453 grants matching “tuberculosis”
Initiation of the Immune Response to M. tuberculosis
$526,128Joel D. Ernst · New York University School Of Medicine · R01 · FY2012 · AI
A QTRAP 6500 LC-MS/MS System from SCIEX for high accuracy drug content analysis
$526,083Veronique Dartois · Rbhs-New Jersey Medical School · S10 · FY2017 · OD
Th1 Cell Apoptosis in Tuberculosis
$526,052Temple University · R01 · FY2003 · AI
Innate Determinants of Microbial Immunity
$525,930Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Validation and Application of a Model for Human-like TB Latency in Rabbits
$525,694David Alland · Rbhs-New Jersey Medical School · U19 · FY2020 · AI
MmpL3 as a target for novel anti-TB agents
$525,678Mary Jackson · Colorado State University · R01 · FY2018 · AI
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 2/2)
$525,645Gabriel Chamie · University Of California, San Francisco · U01 · FY2019 · AA
SELF-SPLICING INTEINS: FUNCTION, EVOLUTION, APPLICATION
$525,626Marlene Belfort · State University Of New York At Albany · R01 · FY2012 · GM
Structure and Modeling
$525,309Timothy A Cross · Florida State University · P01 · FY2009 · AI
Tuberculosis studies in South Africa
$525,226Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Exploring the metabolism of non-replicating and drug-resistant TB
$525,226Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Experimental Animal Models of TB: Chemotherapeutics and Imaging
$525,226Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Development Of New Chemotherapeutics For Tuberculosis
$525,226Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Partnership for TB and TB/HIV Research
$525,100National Institute Of Allergy And Infectious Diseases · Y01 · FY2013 · AI
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infection
$525,006Robert Owen Watson · Texas A&M University Health Science Ctr · R01 · FY2022 · AI
HIV-1 regulation by MTb: pathogen and host factor
$525,000Anne Goldfeld · Immune Disease Institute, Inc. · R56 · FY2010 · AI
Cell Migration in Tuberculosis Infection
$524,788Yeshiva University · R01 · FY2002 · HL
JHU- Optimal regimen development on a Ribosome inhibitor backbone.
$524,782Eric L Nuermberger · Global Alliance For Tb Drug Development · U19 · FY2019 · AI
Heminth Modulation of Mtb
$524,720Padmini Salgame · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2007 · AI
Bacterial RNAP sigma factor structure and function
$524,654Seth A Darst · Rockefeller University · R01 · FY2012 · GM
Uncultured bacteria for the discovery of novel antimicrobials
$524,361Amy Lynn Spoering · Northeastern University · P01 · FY2016 · AI
CD8 T cell and B cell collaboration following subunit vaccination
$524,245Ross M Kedl · University Of Colorado Denver · R01 · FY2020 · AI
Coping With HIV/AIDS in Tanzania
$524,098Kathryn Whetten · Duke University · R01 · FY2008 · MH
Regulators of IFN-gamma responses during Mycobacterium tuberculosis infection
$523,984Andrew Olive · Michigan State University · R01 · FY2024 · AI
Regulators of IFN-gamma responses during Mycobacterium tuberculosis infection
$523,984Andrew Olive · Michigan State University · R01 · FY2022 · AI